Drop AMC and buy GOVX For Maximum Gains; The Best Bitcoin Mining Stock And Cancer Therapy - SPRT, MARA, RIOT, NVCR

 It's time for WSB retards to give up on the dream of AMC ever going anywhere. It's not like GME. They are hoping that AMC will go up, but it already has gone up a lot by market cap. The chart below shows in the last six months that AMC's stock price has gone up 150%, but its market cap has gone up 919%. Why is this? Because AMC's shares outstanding have gone up from about 120 million to 450 million during that time.

Shorters aren't selling you shares cheaply, it's AMC's own management that is selling you shares. We have seen people upset about the vote to increase the authorized shares to over one billion from 500 million. They are angry at management. But why would you want to invest in a company that is actively working against shareholder interests? AMC management will get its way and will use the stock as currency to pay their own expenses. They don't care about shareholders or the stock price. It's a complete waste of time and money to be diamond hands on AMC. 





Instead of AMC, GOVX is a much better stock. If everyone sold their AMC stock which is going nowhere and instead bought GOVX with that money, it could probably go to $50 or $100 from $6. Don't be afraid to sell at a loss on AMC when another stock can make you back all that money and more. GOVX has only 6.3 million shares outstanding and $20 million in cash; $10 million raised from a financing done at $6.25 a few weeks ago. You can buy the stock for cheaper than that right now. GOVX is a vaccine stock, including COVID-19, and has multiple catalysts coming out in the next couple of months


GOVX's volume has been increasing lately, highlighted by a spike of more than triple the entire shares outstanding on Friday. The activity looked like a pump and dump, but it traded really strongly in the two days since, increasing 24% in those two days. Its close at $5.82 on Tuesday means it is back close to the $6.19 high made on Friday. 


Bitcoin keeps going up, challenging $64,000 this evening. MARA and RIOT, two miners have reacted very positively to this news. But one miner that is falling under the radar is SPRT at around $5. SPRT signed a deal to merge with Greenidge, a Bitcoin miner with its own source of power. The Greenidge presentation shows how it is comparable or superior to other top publicly traded Bitcoin miners out there:


There are two articles on Seeking Alpha about this deal, both of which calculate a 2-3x upside for SPRT just to come in line with RIOT's valuation once the merger with Greenidge is complete:

https://seekingalpha.com/article/4418859-greenidge-generation-holdings-stock-minimal-downside-165-percent-upside

https://seekingalpha.com/article/4418378-support-stock-profitable-bitcoin-miner-greenidge-available-at-discount


The first article includes this chart that clearly outlines a good argument for SPRT to be in the $10-$15 range based on RIOT's stock price being $55 to $60. 

Another stock to pay close attention to is NVCR, which rose 50% on Tuesday after the Data Monitoring Committee (DMC) recommended a reduced trial duration and patient numbers in its phase 3 trial for its Tumor Trial Fields treatment for non-small cell lung cancer. Tumor Treating Fields is a device that treats solid tumor cancers by using electro-fields to interrupt the cell division process that causes cancer to grow and spread. This is apparently working so well that the DMC said that it's unethical for patients in the control arm to continue to 18 months of follow-up and recommended a reduced sample size of 276 patients with 12 months of follow-up. It's better for these people to get the treatment rather than be part of the control group. This outstanding news means this stock is likely to be a multi-day runner and the device can probably apply to all sorts of cancers, making the potential market size in the many billions. 

Comments

Popular posts from this blog

Carvana: The Gamma Squeeze is Real, Time to Bankrupt Kerrisdale

The Next NVDA-Backed Runner and New Asian IPO Squeeze Play

CVNA Squeezing, ROOT and RXRX are Next